Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C15H14ClNO2S.ClH |
Molecular Weight | 344.256 |
Optical Activity | ( + ) |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.OC(=O)[C@@H](N1CCC2=C(C1)C=CS2)C3=CC=CC=C3Cl
InChI
InChIKey=FOKSIOUPGDBSLC-UQKRIMTDSA-N
InChI=1S/C15H14ClNO2S.ClH/c16-12-4-2-1-3-11(12)14(15(18)19)17-7-5-13-10(9-17)6-8-20-13;/h1-4,6,8,14H,5,7,9H2,(H,18,19);1H/t14-;/m0./s1
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C15H14ClNO2S |
Molecular Weight | 307.795 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Stability indicating HPTLC determination of clopidogrel bisulphate as bulk drug and in pharmaceutical dosage form. | 2003 Dec 4 |
|
Aspirin "failures," clopidogrel added to aspirin, and secondary stroke prevention in veterans presenting with TIA or mild-to-moderate ischemic stroke. | 2003 Jan |
|
Risk factor awareness and secondary prevention of coronary artery disease: are we doing enough? | 2006 Jun |
|
Management of atrial fibrillation. | 2007 |
|
Epidemiology, classification, and modifiable risk factors of peripheral arterial disease. | 2007 |
|
[Modified platelet aggregation test in patients on ASA and/or clopidogrel]. | 2007 Aug |
|
Con: continuation of aspirin/clopidogrel for cardiac surgery. | 2007 Aug |
|
Pro: continuation of aspirin/clopidogrel for cardiac surgery. | 2007 Aug |
|
Evidence-based use of medications in patients with coronary artery disease in a rural Australian community. | 2007 Aug |
|
Anithrombotic prevention in vascular disease: bases for a new strategy in antithrombotic therapy. | 2007 Aug 29 |
|
Quality assessment of platelet rich plasma during anti-platelet therapy. | 2007 Jan |
|
[Interindividual variability in the laboratory response to the aspirin-clopidogrel combination: are patients with stent occlusion "resistant" to treatment?]. | 2007 May |
|
A novel P2Y(12) adenosine diphosphate receptor antagonist that inhibits platelet aggregation and thrombus formation in rat and dog models. | 2007 May |
|
To adjust or not to adjust the platelet count in light transmission aggregometry in patients receiving dual aspirin/clopidogrel treatment. | 2007 Nov |
|
Antiplatelet drug therapy moderates immune-mediated liver disease and inhibits viral clearance in mice infected with a replication-deficient adenovirus. | 2007 Nov |
|
Utilisation review of clopidogrel: are they used under the FDA-approved indications? | 2007 Sep |
|
Platelet aggregation and recruitment with aspirin-clopidogrel therapy. | 2008 |
|
Trends in usage of alternative antiplatelet therapy after stroke and transient ischemic attack. | 2008 Apr |
|
Evidence for prolonged prescribing of aspirin-clopidogrel combination in Scottish primary care. | 2008 Apr |
|
[Effect of nattokinase on restenosis after percutaneous transluminal angioplasty of the abdominal artery in rabbits]. | 2008 Aug |
|
Determination of clopidogrel main metabolite in plasma: a useful tool for monitoring therapy? | 2008 Feb |
|
Effect of clopidogrel pretreatment on angiographic and clinical outcomes in patients undergoing primary percutaneous coronary intervention for ST-elevation acute myocardial infarction. | 2008 Feb 15 |
|
Repeat oral dosing of prasugrel, a novel P2Y12 receptor inhibitor, results in cumulative and potent antiplatelet and antithrombotic activity in several animal species. | 2008 Jan 28 |
|
The single individual in medicine: how to escape from the probability theory trap. | 2008 Jul 24 |
|
Chemometric simultaneous estimation of clopidogrel bisulphate and aspirin from combined dosage form. | 2008 Jul-Aug |
|
Percutaneous heartworm removal from dogs with severe heart worm (Dirofilaria immitis) infestation. | 2008 Jun |
|
Development and metrological characterization of quantitative X-ray diffraction phase analysis for the mixtures of clopidogrel bisulphate polymorphs. | 2008 Mar 13 |
|
Rapid LC-ESI-MS-MS method for the simultaneous determination of clopidogrel and its carboxylic acid metabolite in human plasma. | 2008 Nov-Dec |
|
In situ monitoring of polymorph transformation of clopidogrel hydrogen sulfate using measurement of ultrasonic velocity. | 2008 Oct |
|
[Bleeding and thromboembolic risk. Perioperative strategy in aspirin/clopidogrel]. | 2009 |
|
Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: a randomized dose-guiding, safety, and tolerability study of four doses of AZD0837 vs. vitamin K antagonists. | 2009 Dec |
|
Clopidogrel versus prasugrel in rabbits. Effects on thrombosis, haemostasis, platelet function and response variability. | 2009 Jan |
|
Quantifying low levels of polymorphic impurity in clopidogrel bisulphate by vibrational spectroscopy and chemometrics. | 2009 Jan 15 |
|
Antiplatelet drugs and the perioperative period: What every urologist needs to know. | 2009 Jul |
|
Treatment for blunt cerebrovascular injuries: equivalence of anticoagulation and antiplatelet agents. | 2009 Jul |
|
Effects of prasugrel, a novel P2Y(12) inhibitor, in rat models of cerebral and peripheral artery occlusive diseases. | 2009 Jun 10 |
|
Optimizing long-term dual aspirin/clopidogrel therapy in acute coronary syndromes: when does the risk outweigh the benefit? | 2009 Mar 20 |
|
Comparison of VerifyNow-P2Y12 test and Flow Cytometry for monitoring individual platelet response to clopidogrel. What is the cut-off value for identifying patients who are low responders to clopidogrel therapy? | 2009 May 6 |
|
Clopidogrel/aspirin combination therapy in high-risk atrial fibrillation patients. | 2009 May-Jun |
|
A validated enantiospecific method for determination and purity assay of clopridogrel. | 2009 Nov |
|
Late-onset erythromelalgia in a previously healthy young woman: a case report and review of the literature. | 2009 Nov 4 |
|
Randomized controlled trial of aspirin and clopidogrel versus aspirin and placebo on markers of smooth muscle proliferation before and after peripheral angioplasty. | 2009 Oct |
|
Use of aspirin versus clopidogrel plus aspirin after coronary artery bypass graft surgery. | 2009 Oct |
|
Comparing the antiplatelet effect of clopidogrel hydrogensulfate and clopidogrel besylate: a crossover study. | 2009 Sep |
|
Preliminary evidence of a high risk of bleeding on aspirin plus clopidogrel in aspirin-naïve patients in the acute phase after TIA or minor ischaemic stroke. | 2010 |
|
Variability of residual platelet function despite clopidogrel treatment in patients with peripheral arterial occlusive disease. | 2010 Apr |
|
Paclitaxel-eluting versus sirolimus-eluting stents in diabetes mellitus: a report from the National Heart, Lung, and Blood Institute Dynamic Registry. | 2010 Feb 1 |
|
Characterization of degradation products of amorphous and polymorphic forms of clopidogrel bisulphate under solid state stress conditions. | 2010 Jul 8 |
|
Modern role for clopidogrel in management of atrial fibrillation and stroke reduction. | 2010 Mar 3 |
|
Effect of sample preparation method on quantification of polymorphs using PXRD. | 2010 Sep-Oct |
Patents
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 20:18:42 GMT 2023
by
admin
on
Sat Dec 16 20:18:42 GMT 2023
|
Record UNII |
M6F4R2R78A
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
45358950
Created by
admin on Sat Dec 16 20:18:43 GMT 2023 , Edited by admin on Sat Dec 16 20:18:43 GMT 2023
|
PRIMARY | |||
|
M6F4R2R78A
Created by
admin on Sat Dec 16 20:18:43 GMT 2023 , Edited by admin on Sat Dec 16 20:18:43 GMT 2023
|
PRIMARY | |||
|
144750-42-5
Created by
admin on Sat Dec 16 20:18:43 GMT 2023 , Edited by admin on Sat Dec 16 20:18:43 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
RACEMATE -> ENANTIOMER |
|
||
|
PARENT -> SALT/SOLVATE |
|